Scoggin Management’s Pfizer PFE Stock Holding History

Scoggin Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-542,810	Closed	-$15.3M	–	57
2016 Q1	$15.3M	Buy	542,810 +295,120	+119%	+$8.43M	1.61%	19
2015 Q4	$7.59M	Buy	+247,690	New	+$7.79M	1.12%	31
2015 Q1	–	Sell	-1,387,064	Closed	-$41M	–	122
2014 Q4	$41M	Sell	1,387,064 -852,686	-38%	-$24.4M	3.72%	7
2014 Q3	$62.8M	Buy	+2,239,750	New	+$62.9M	3.33%	5

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Scoggin Management's PFE Position: Q1 2016 in Review

Scoggin Management sold out of Pfizer (PFE) in Q1 2016, closing a stake of 537,540 shares — an estimated $15.4M sold.

Scoggin Management first reported a position in PFE in Q2 2013 and held it in 5 quarters. The position peaked at $18.4M in Q2 2013. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Scoggin Management reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
Scoggin Management sold 537,540 Pfizer shares in Q1 2016, an estimated $15.4M.
Scoggin Management first reported a position in Pfizer in Q2 2013 and held it in 5 quarters.
Scoggin Management's Pfizer position peaked at $18.4M in Q2 2013.
1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Scoggin Management's 13F filing for Q1 2016, filed 12 May 2016.